Showing posts with label positive results from MD1003 Phase III trial in patients with progressive MS. Show all posts
Showing posts with label positive results from MD1003 Phase III trial in patients with progressive MS. Show all posts
Tuesday, September 29, 2015

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

›
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Ph...